Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisahide Nishio

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
The Lancet. Child & Adolescent Health|January 20, 2023
Newborn screening for spinal muscular atrophyHisahide Nishio
Journal of Human Genetics|November 29, 2013
PLS3 expression and SMA phenotype: a commentary on correlation of PLS3 expression with disease severity in children with spinal muscular atrophyHisahide Nishio
Genes|September 27, 2025
Editorial: Special Issue "Genetic Newborn Screening"Hisahide Nishio, Hiroyuki Awano
The Kobe Journal of Medical Sciences|June 13, 2013
Study abroad experience is related to Japanese doctors' behavior to see foreign patientsKinko Tamamaki, Hisahide Nishio
Allergology International : Official Journal of the Japanese Society of Allergology|August 25, 2009
Comparison of the bronchodilative effects of salbutamol delivered via three mesh nebulizers in children with bronchial asthmaFumitake Kurosaka, Hisahide Nishio
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 6, 2018
Can urinary titin be used for predicting Duchenne muscular dystrophy?Masafumi Matsuo, Hiroyuki Awano, Hisahide Nishio
Journal of Human Genetics|February 27, 2015
A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencingYuji Kubo, Hisahide Nishio, Kayoko Saito
Brain & Development|June 23, 2015
Contributions of Japanese patients to development of antisense therapy for DMDMasafumi Matsuo, Yasuhiro Takeshima, Hisahide Nishio
International Journal of Molecular Sciences|May 14, 2022
An Antisense Oligonucleotide against a Splicing Enhancer Sequence within Exon 1 of the <i>MSTN</i> Gene Inhibits Pre-mRNA Maturation to Act as a Novel Myostatin InhibitorKazuhiro Maeta, Manal Farea, Hisahide Nishio, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 15, 2023
A novel splice variant of the human MSTN gene encodes a myostatin-specific myostatin inhibitorKazuhiro Maeta, Manal Farea, Hisahide Nishio, et al.
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
The Lancet. Child & Adolescent Health|January 20, 2023
Newborn screening for spinal muscular atrophyHisahide Nishio
Journal of Human Genetics|November 29, 2013
PLS3 expression and SMA phenotype: a commentary on correlation of PLS3 expression with disease severity in children with spinal muscular atrophyHisahide Nishio
Genes|September 27, 2025
Editorial: Special Issue "Genetic Newborn Screening"Hisahide Nishio, Hiroyuki Awano
The Kobe Journal of Medical Sciences|June 13, 2013
Study abroad experience is related to Japanese doctors' behavior to see foreign patientsKinko Tamamaki, Hisahide Nishio
Allergology International : Official Journal of the Japanese Society of Allergology|August 25, 2009
Comparison of the bronchodilative effects of salbutamol delivered via three mesh nebulizers in children with bronchial asthmaFumitake Kurosaka, Hisahide Nishio
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 6, 2018
Can urinary titin be used for predicting Duchenne muscular dystrophy?Masafumi Matsuo, Hiroyuki Awano, Hisahide Nishio
Journal of Human Genetics|February 27, 2015
A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencingYuji Kubo, Hisahide Nishio, Kayoko Saito
Brain & Development|June 23, 2015
Contributions of Japanese patients to development of antisense therapy for DMDMasafumi Matsuo, Yasuhiro Takeshima, Hisahide Nishio
International Journal of Molecular Sciences|May 14, 2022
An Antisense Oligonucleotide against a Splicing Enhancer Sequence within Exon 1 of the <i>MSTN</i> Gene Inhibits Pre-mRNA Maturation to Act as a Novel Myostatin InhibitorKazuhiro Maeta, Manal Farea, Hisahide Nishio, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 15, 2023
A novel splice variant of the human MSTN gene encodes a myostatin-specific myostatin inhibitorKazuhiro Maeta, Manal Farea, Hisahide Nishio, et al.
Pageof 18